TheraDiag
TheraDiag is a France-based company specializing in the development, manufacturing, and marketing of in-vitro diagnostic products. Founded in 1986 and headquartered in Marne La Vallée, the company offers a range of diagnostic tools, including reagents for autoimmune and infectious diseases, as well as fertility tests. Notable products include IMMUNO-TROL, a quality control tool; various instruments for disease testing; and the SQA-V semen analyzer. TheraDiag also provides advanced instrumentation such as the Theralis platform, which integrates immunofluorescence and ELISA technologies, and the FIDIS platform for laboratory analysis. Additionally, the company offers therapeutic drug monitoring services for chronic inflammatory diseases and LISA tracker, a tool designed for monitoring biotherapies.
Top Sectors
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
1 past transactions
Prestizia
Acquisition in 2012
Prestizia is a biotechnology company specializing in the development of innovative diagnostic tools. It holds an exclusive global license for a patented method using microRNA signatures to characterize HIV cell tropism, with potential applications in identifying treatable HIV patients and differentiating cancer types. The company offers research and development services tailored to viral infections and human malignancies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.